For research use only
| Cat No. | ABC-SC0044T |
| Product Type | Animal Mesenchymal Stem Cells |
| Cell Type | Mesenchymal Stem Cell |
| Species | Mouse |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HighQC™ C57BL/6 Mouse Lung MSCs enable studies of lung repair, mesenchymal lineage differentiation, and pulmonary fibrosis in mouse stem cell models.
HighQC™ C57BL/6 Mouse Lung Mesenchymal Stem Cells (MSCs) are derived from the lung tissues of adult C57BL/6 mice. The cells exhibit a characteristic fibroblast-like, spindle-shaped morphology in standard culture conditions. During lung injury, the bioactive lipid lysophosphatidic acid (LPA) is released from numerous cells, which activates the LPAR1 receptor on lung-resident MSCs (LR-MSCs), causing the LR-MSCs to migrate and differentiate into fibroblasts. These MSCs offer a biologically relevant tool for probing fibrotic mechanisms and immunomodulation in preclinical lung models. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from mycoplasma, fungi, yeast, and bacteria.
| Product Code | HighQC™ C57BL/6 Mouse Lung Mesenchymal Stem Cell, C57BL/6 Lung MSC, C57-mL-MSC, Mouse Lung MSC |
| Species | Mouse |
| Cat.No | ABC-SC0044T |
| Product Category | Stem Cells |
| Size/Quantity | 1 vial |
| Cell Type | Mesenchymal Stem Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Lung |
| Disease | Normal |
| Storage | Liquid Nitrogen |
| Product Type | Animal Mesenchymal Stem Cells |
HighQC™ C57BL/6 Mouse Lung Mesenchymal Stem Cells serve as a physiologically relevant in vitro model for investigating pulmonary regenerative mechanisms and disease pathogenesis. These C57 mouse pulmonary mesenchymal cells are particularly valuable in murine models of chronic lung disease, enabling researchers to elucidate mesenchymal-immune interactions, immunomodulation, and fibrotic differentiation. This facilitates targeted studies of extracellular matrix (ECM) remodeling and epithelial-mesenchymal transition (EMT) in conditions such as idiopathic pulmonary fibrosis, thereby advancing therapeutic discovery for epithelial-mesenchymal crosstalk dysregulation.
When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).